$EDAP News
Last published 3mo ago
- 3mo agoEDAPFOCLFocalTherics (Formerly EDAP) Second Quarter 2026 Earnings Conference Call - EDAP TMS SAEarnings Call TranscriptsGood afternoon, everyone. Welcome to today's Focal Therix second quarter 2026 conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, you will have the opportunity to ask qu
- 3mo agoEDAPFOCLFocalTherics (Formerly EDAP) Second Quarter 2026 Earnings Conference Call - EDAP TMS SAEarnings Call TranscriptsGood afternoon, everyone. Welcome to today's Focal Therix second quarter 2026 conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, you will have the opportunity to ask qu
- 5mo agoEDAPEDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal TherapyGlobeNewswire, May 29, 2026 (GLOBE NEWSWIRE) -- EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol
- 5mo agoEDAPEDAP | Focal One to Present at Jefferies 2026 Global Healthcare ConferenceGlobeNewswire, May 21, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference Company to Present and Host 1x1 Investor Meetings on Thursday, June 4th, 2026 AUSTIN, Texas, May
- 6mo agoEDAPPROFTLXTelix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment ApproachesGlobeNewswireTelix to partner with companies developing advanced minimally invasive and image-guided ablative technologies for prostate cancer.Initial focus on patient selection, treatment planning and post-treatment monitoring;
- 6mo agoEDAPTLXEDAP | Focal One and Telix Announce Collaboration Focused on Robotic HIFU and Theranostics in Prostate CancerGlobeNewswire, May 14, 2026 (GLOBE NEWSWIRE) -- AUSTIN, Texas – May 14, 2026 – EDAP TMS S.A. (NASDAQ:EDAP) today announced that it has entered into a letter of intent with Telix Pharmaceuticals Limited ("Telix") to explore joint
- 6mo agoEDAPEDAP | Focal One to Host Investor Day on June 1, 2026GlobeNewswire, May 13, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Host Investor Day on June 1, 2026 AUSTIN, Texas, May 13, 2026 -- EDAP TMS SA (NASDAQ:EDAP) (the "Company"), the global leader in robotic energy-based
- 6mo agoEDAPEDAP Reports Strong Financial Results with Record First Quarter HIFU RevenueGlobeNewswire, May 07, 2026 (GLOBE NEWSWIRE) -- EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue Seventh Consecutive Quarter of Year-Over-Year HIFU Revenue Growth 78% Growth in First Quarter HIFU
- 6mo agoEDAPEDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate CancerGlobeNewswire, April 30, 2026 (GLOBE NEWSWIRE) -- EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer AUSTIN, Texas, April 30, 2026 - EDAP TMS
- 6mo agoEDAPEDAP to Announce First Quarter 2026 Financial Results on May 7, 2026GlobeNewswire, April 16, 2026 (GLOBE NEWSWIRE) -- EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026 Company to host conference call and webcast on Thursday, May 7 at 8:30 a.m. EDT AUSTIN, Texas, April 16, 2026
- 7mo agoEDAPEDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU RevenueGlobeNewswireEDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue 39% Full-Year YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in the Number of U.S. Focal One
- 8mo agoEDAPEDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services ConferenceGlobeNewswireEDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Company to Present and Host 1x1 Investor Meetings on Wednesday, March 18th, 2026 AUSTIN, Texas, March 10, 2026 -- EDAP TMS SA
- 8mo agoEDAPEDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026GlobeNewswireEDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 Company to host conference call and webcast on Wednesday, March 25 at 8:30 a.m. EDT AUSTIN, Texas, March 4, 2026 -- EDAP TMS SA
- 9mo agoEDAPEDAP Announces Appointment of David Horn to Board of DirectorsGlobeNewswireEDAP Announces Appointment of David Horn to Board of Directors AUSTIN, Texas, February 12, 2026 – EDAP TMS S.A. (NASDAQ:EDAP) ("the Company" or "EDAP"), a global leader in therapeutic ultrasound technology,
- 10mo agoEDAPEDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue GuidanceGlobeNewswireEDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance 36% to 38% Annual YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System
- 11mo agoEDAPEDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFUGlobeNewswireEDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU AUSTIN, Texas, November 20, 2025 - EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based therapies, today announced that
- 11mo agoEDAPEDAP to Present at Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireEDAP to Present at Piper Sandler 37th Annual Healthcare Conference Company to Present and Host 1x1 Investor Meetings on Tuesday, December 2nd, 2025 AUSTIN, Texas, November 18, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the
- 1y agoEDAPEDAP Reports Third Quarter 2025 Financial ResultsGlobeNewswireEDAP Reports Third Quarter 2025 Financial Results 49% YoY HIFU Revenue Growth, Driven by Increased Focal One® Sales and U.S. Procedure Volumes167% YoY Growth in Focal One System Placements15% YoY Growth in U.S.
- 1y agoEDAPEDAP to Present at Jefferies Global Healthcare Conference in LondonGlobeNewswireEDAP to Present at Jefferies Global Healthcare Conference in London Company to Present and Host 1x1 Investor Meetings on Tuesday, November 18th, 2025 AUSTIN, Texas, November 4, 2025 -- EDAP TMS SA (NASDAQ:EDAP)
- 1y agoEDAPEDAP to Participate in the UBS Global Healthcare ConferenceGlobeNewswireEDAP to Participate in the UBS Global Healthcare Conference Company to Host 1x1 Investor Meetings on Monday, November 10th, 2025 AUSTIN, Texas, October 27, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the
- 1y agoEDAPEDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025GlobeNewswireEDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025 Company to host conference call and webcast on Thursday, November 6th at 8:30am EST AUSTIN, Texas, October 23, 2025 -- EDAP TMS SA (NASDAQ:EDAP)
- 1y agoEDAPEDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFUGlobeNewswireEDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU Lyon, France – October 20, 2025 – EDAP TMS SA (NASDAQ:EDAP) ("EDAP" or the
- 1y agoGTBPEVAXRNXTEDAP+1Natural Killer Cell Therapies Lead $254B Immunotherapy Market TransformationPR NewswireEquity InsiderNews Commentary – MIT and Harvard scientists recently created engineered CAR-NK cells that hide from the immune system and more...
- 1y agoEDAPFocal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment OptionGlobeNewswireFocal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option Focal One Robotic HIFU Patient Story Featured on Health Uncensored with Dr. Drew on Lifetime Network AUSTIN,
- 1y agoEDAPFocal One® HIFU Receives Prestigious Innovation AwardGlobeNewswireFocal One® HIFU Receives Prestigious Innovation Award AUSTIN, Texas, September 16, 2025 - EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based therapies, announced today that the company
- 1y agoEDAPEDAP Receives HIFU Reimbursement for Prostate Cancer in FranceGlobeNewswireFocal One Robotic HIFU procedure now covered under France's national universal health systemReimbursement milestone allows increased patient access to Focal One Robotic HIFU AUSTIN, Texas, September 8, 2025 - EDAP TMS
- 1y agoEDAPEDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call TranscriptEarnings Call Transcripts
- 1y agoEDAPEDAP Reports Strong Second Quarter 2025 HIFU ResultsGlobeNewswire+140% Focal One® Net Placement Growth Year over Year+76.8% HIFU Revenue Growth Year over Year 36 million Euro Credit Facility Letter of Intent Executed with European Investment Bank (EIB) to further accelerate HIFU
- 1y agoEDAPEDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic ExpansionGlobeNewswireFunding to Support Continued Growth of Focal One® Robotic HIFU AUSTIN, Texas, August 26, 2025 - EDAP TMS SA (NASDAQ:EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, today
- 1y agoEDAPEDAP to Participate in the H.C. Wainwright 27th Annual Global Investment ConferenceGlobeNewswireAUSTIN, Texas, August 25, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to participate in
- 1y agoEDAPEDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025GlobeNewswireCompany to host conference call and webcast on Thursday, August 28th at 8:30am EDT AUSTIN, Texas, August 7, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic energy-based therapies, today
- 1y agoEDAPEDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer StatusGlobeNewswireTransition to U.S. reporting status to take effect on January 1, 2026 AUSTIN, Texas, July 1, 2025 - EDAP TMS SA (NASDAQ:EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, announced a
- 1y agoEDAPEDAP to Present at the Jefferies Global Healthcare ConferenceGlobeNewswireAUSTIN, Texas, May 27, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a
- 1y agoEDAPEDAP Reports First Quarter 2025 Financial ResultsGlobeNewswireAchieved a Record Number of Focal One® Robotic HIFU System Placements for a First Quarter Period Received CE Mark Designation for Focal One for the Treatment of Deep Infiltrating Endometriosis Positive
- 1y agoEDAPEDAP to Announce First Quarter 2025 Financial Results on May 15, 2025GlobeNewswireCompany to host conference call and webcast on Thursday, May 15th at 8:30am EDT LYON, France, May 1, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic energy-based therapies, today
- 1y agoEDAPEDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual MeetingGlobeNewswireFinal 3-year outcome of Focal Ablation versus Radical Prostatectomy (FARP) Randomized Controlled Trial (RCT) presented at 120th AUA Annual Meeting on Sunday, April 27, 2025. Study achieved its primary endpoint and
- 1y agoEDAPEDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual MeetingGlobeNewswireFocal One i expands HIFUsion® patient-specific imaging compatibility to include PSMA PET, ExactVu™ Micro-Ultrasound, along with AI-driven and intelligent algorithms including Unfold AI™ and OnQ™
- 1y agoEDAPEDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual MeetingGlobeNewswireActivities to include expert-led demonstrations, semi-live Focal One procedures and hands-on simulations Final results of randomized clinical trial (FARP Study) comparing ultrasound-based focal ablation versus radical
- 1y agoEDAPEDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 ResultsGlobeNewswireRecord full-year 2024 HIFU revenue of USD 25.7 million, an increase of 15.3% over full-year 2023Record Q4 2024 HIFU revenue of USD 9.3 million, an increase of 15.0% over Q4 2023U.S. Focal One HIFU
- 1y agoEDAPEDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025GlobeNewswireCompany to host conference call and webcast on Thursday, March 27th at 8:30am EDT AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company"), the global leader in robotic energy-based therapies, today
- 1y agoEDAPLUNGEDAP Appoints Glen French to Board of DirectorsGlobeNewswirePDF Version LYON, France, March 3, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, today announced the appointment of Glen French to its Board of
- 1y agoEDAPCortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer CenterGlobeNewswireFirst Focal One® procedure utilizing Cortechs.ai's advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer CenterOnQ Prostate's
- 1y agoEDAPEDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. ProceduresGlobeNewswireCompany Reports Preliminary Worldwide Record Fourth Quarter Sales of 11 Focal One Systems Record U.S. Fourth Quarter Focal One System Sales Record Number of U.S. Focal One Procedures, with Year-Over-Year Growth of 30%
- 1y agoEDAPBLUDMNTEDAP Appoints Joshua H. Levine to Board of DirectorsGlobeNewswirePDF Version AUSTIN, Texas, January 10, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, today announced the appointment of Joshua H. Levine to its Board
- 1y agoEDAPEDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU TechnologyGlobeNewswireAUSTIN, Texas, January 8, 2025 - EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre
- 1y agoEDAPLandmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate CancerGlobeNewswireHIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatmentsPositive study results are expected to drive further adoption of
- 1y agoEDAPSNTISenti Bio Appoints Fran Schulz to Board of DirectorsGlobeNewswireSOUTH SAN FRANCISCO, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio" or the "Company"), a clinical-stage biotechnology company developing next-generation cell and gene
- 1y agoEDAPEDAP to Participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswireLYON, France, November 27, 2024 - EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer of EDAP TMS, is scheduled to participate in
- 1y agoEDAPEDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America MeetingGlobeNewswireEarly feasibility work demonstrates Focal One system's ability to generate histotripsy lesions ex vivo LYON, France, November 22, 2024 - EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based
- 1y agoEDAPEDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating EndometriosisGlobeNewswireTreatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery LYON, France, November 19, 2024 - EDAP TMS SA (NASDAQ:EDAP), the